Orphan Drugs Market
Orphan Drugs Market - Global Industry Assessment & Forecast
#
Pages:
215
Base Year:
2023
Dec - 2024
Format:
Report Code:
VMR-VMR-2021-0236
Segments Covered
By
Therapy Type Oncology, Hematology, Neurology, Endocrinology, Cardiovascular, Respiratory, Immunotherapy, Infectious Diseases, Others
-
By
Drug Type Biologics, Non-biologics
-
By
Distribution Channel Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2023 |
| Forecast
Years:
|
2024 - 2032 |
 Historical
Years:
|
2018 - 2022 |
 Revenue
2023: |
USD 177 Billion |
 Revenue 2032:
|
USD 505 Billion |
 Revenue CAGR
(2024 - 2032): |
12.4% |
Fastest Growing Region (2024 -
2032)
|
Europe |
Largest Region (2023):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Orphan Drugs Market Segment Analysis
- Orphan Drugs Therapy Type Outlook (Revenue, USD Million, 2018 - 2030)
- Oncology
- Hematology
- Neurology
- Endocrinology
- Cardiovascular
- Respiratory
- Immunotherapy
- Infectious Diseases
- Others
- Orphan Drugs Drug Type Outlook (Revenue, USD Million, 2018 - 2030)
- Biologics
- Non-biologics
- Orphan Drugs Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America Orphan Drugs Market, by Therapy Type
- Oncology
- Hematology
- Neurology
- Endocrinology
- Cardiovascular
- Respiratory
- Immunotherapy
- Infectious Diseases
- Others
-
North America Orphan Drugs Market, by Drug Type
- Biologics
- Non-biologics
-
North America Orphan Drugs Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
- U.S.
- U.S. Orphan Drugs Market, by Therapy Type
- Oncology
- Hematology
- Neurology
- Endocrinology
- Cardiovascular
- Respiratory
- Immunotherapy
- Infectious Diseases
- Others
- U.S. Orphan Drugs Market, by Drug Type
- Biologics
- Non-biologics
- U.S. Orphan Drugs Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
- U.S. Orphan Drugs Market, by Therapy Type
- Canada
- Canada Orphan Drugs Market, by Therapy Type
- Oncology
- Hematology
- Neurology
- Endocrinology
- Cardiovascular
- Respiratory
- Immunotherapy
- Infectious Diseases
- Others
- Canada Orphan Drugs Market, by Drug Type
- Biologics
- Non-biologics
- Canada Orphan Drugs Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
- Canada Orphan Drugs Market, by Therapy Type
-
Mexico
- Mexico Orphan Drugs Market, by Therapy Type
- Oncology
- Hematology
- Neurology
- Endocrinology
- Cardiovascular
- Respiratory
- Immunotherapy
- Infectious Diseases
- Others
- Mexico Orphan Drugs Market, by Drug Type
- Biologics
- Non-biologics
- Mexico Orphan Drugs Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
- Mexico Orphan Drugs Market, by Therapy Type
-
North America Orphan Drugs Market, by Therapy Type
- Europe
-
Europe Orphan Drugs Market, by Therapy Type
- Oncology
- Hematology
- Neurology
- Endocrinology
- Cardiovascular
- Respiratory
- Immunotherapy
- Infectious Diseases
- Others
-
Europe Orphan Drugs Market, by Drug Type
- Biologics
- Non-biologics
-
Europe Orphan Drugs Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
- U. K.
- U.K. Orphan Drugs Market, by Therapy Type
- Oncology
- Hematology
- Neurology
- Endocrinology
- Cardiovascular
- Respiratory
- Immunotherapy
- Infectious Diseases
- Others
- U.K. Orphan Drugs Market, by Drug Type
- Biologics
- Non-biologics
- U.K. Orphan Drugs Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
- U.K. Orphan Drugs Market, by Therapy Type
- France
- France Orphan Drugs Market, by Therapy Type
- Oncology
- Hematology
- Neurology
- Endocrinology
- Cardiovascular
- Respiratory
- Immunotherapy
- Infectious Diseases
- Others
- France Orphan Drugs Market, by Drug Type
- Biologics
- Non-biologics
- France Orphan Drugs Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
- France Orphan Drugs Market, by Therapy Type
-
Germany
- Germany Orphan Drugs Market, by Therapy Type
- Oncology
- Hematology
- Neurology
- Endocrinology
- Cardiovascular
- Respiratory
- Immunotherapy
- Infectious Diseases
- Others
- Germany Orphan Drugs Market, by Drug Type
- Biologics
- Non-biologics
- Germany Orphan Drugs Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
- Germany Orphan Drugs Market, by Therapy Type
-
Italy
- Italy Orphan Drugs Market, by Therapy Type
- Oncology
- Hematology
- Neurology
- Endocrinology
- Cardiovascular
- Respiratory
- Immunotherapy
- Infectious Diseases
- Others
- Italy Orphan Drugs Market, by Drug Type
- Biologics
- Non-biologics
- Italy Orphan Drugs Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
- Italy Orphan Drugs Market, by Therapy Type
-
Spain
- Spain Orphan Drugs Market, by Therapy Type
- Oncology
- Hematology
- Neurology
- Endocrinology
- Cardiovascular
- Respiratory
- Immunotherapy
- Infectious Diseases
- Others
- Spain Orphan Drugs Market, by Drug Type
- Biologics
- Non-biologics
- Spain Orphan Drugs Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
- Spain Orphan Drugs Market, by Therapy Type
-
Rest of Europe
- Rest of Europe Orphan Drugs Market, by Therapy Type
- Oncology
- Hematology
- Neurology
- Endocrinology
- Cardiovascular
- Respiratory
- Immunotherapy
- Infectious Diseases
- Others
- Rest of Europe Orphan Drugs Market, by Drug Type
- Biologics
- Non-biologics
- Rest of Europe Orphan Drugs Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
- Rest of Europe Orphan Drugs Market, by Therapy Type
-
Europe Orphan Drugs Market, by Therapy Type
- Asia Pacific
-
Asia Pacific Orphan Drugs Market, by Therapy Type
- Oncology
- Hematology
- Neurology
- Endocrinology
- Cardiovascular
- Respiratory
- Immunotherapy
- Infectious Diseases
- Others
-
Asia Pacific Orphan Drugs Market, by Drug Type
- Biologics
- Non-biologics
-
Asia Pacific Orphan Drugs Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
- China
- China Orphan Drugs Market, by Therapy Type
- Oncology
- Hematology
- Neurology
- Endocrinology
- Cardiovascular
- Respiratory
- Immunotherapy
- Infectious Diseases
- Others
- China Orphan Drugs Market, by Drug Type
- Biologics
- Non-biologics
- China Orphan Drugs Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
- China Orphan Drugs Market, by Therapy Type
- Japan
- Japan Orphan Drugs Market, by Therapy Type
- Oncology
- Hematology
- Neurology
- Endocrinology
- Cardiovascular
- Respiratory
- Immunotherapy
- Infectious Diseases
- Others
- Japan Orphan Drugs Market, by Drug Type
- Biologics
- Non-biologics
- Japan Orphan Drugs Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
- Japan Orphan Drugs Market, by Therapy Type
-
Germany
- Germany Orphan Drugs Market, by Therapy Type
- Oncology
- Hematology
- Neurology
- Endocrinology
- Cardiovascular
- Respiratory
- Immunotherapy
- Infectious Diseases
- Others
- Germany Orphan Drugs Market, by Drug Type
- Biologics
- Non-biologics
- Germany Orphan Drugs Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
- Germany Orphan Drugs Market, by Therapy Type
-
India
- India Orphan Drugs Market, by Therapy Type
- Oncology
- Hematology
- Neurology
- Endocrinology
- Cardiovascular
- Respiratory
- Immunotherapy
- Infectious Diseases
- Others
- India Orphan Drugs Market, by Drug Type
- Biologics
- Non-biologics
- India Orphan Drugs Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
- India Orphan Drugs Market, by Therapy Type
-
South Korea
- South Korea Orphan Drugs Market, by Therapy Type
- Oncology
- Hematology
- Neurology
- Endocrinology
- Cardiovascular
- Respiratory
- Immunotherapy
- Infectious Diseases
- Others
- South Korea Orphan Drugs Market, by Drug Type
- Biologics
- Non-biologics
- South Korea Orphan Drugs Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
- South Korea Orphan Drugs Market, by Therapy Type
-
South East Asia
- South East Asia Orphan Drugs Market, by Therapy Type
- Oncology
- Hematology
- Neurology
- Endocrinology
- Cardiovascular
- Respiratory
- Immunotherapy
- Infectious Diseases
- Others
- South East Asia Orphan Drugs Market, by Drug Type
- Biologics
- Non-biologics
- South East Asia Orphan Drugs Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
- South East Asia Orphan Drugs Market, by Therapy Type
-
Rest of Asia Pacific
- Rest of Asia Pacific Orphan Drugs Market, by Therapy Type
- Oncology
- Hematology
- Neurology
- Endocrinology
- Cardiovascular
- Respiratory
- Immunotherapy
- Infectious Diseases
- Others
- Rest of Asia Pacific Orphan Drugs Market, by Drug Type
- Biologics
- Non-biologics
- Rest of Asia Pacific Orphan Drugs Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
- Rest of Asia Pacific Orphan Drugs Market, by Therapy Type
-
Asia Pacific Orphan Drugs Market, by Therapy Type
- Latin America
-
Latin America Orphan Drugs Market, by Therapy Type
- Oncology
- Hematology
- Neurology
- Endocrinology
- Cardiovascular
- Respiratory
- Immunotherapy
- Infectious Diseases
- Others
-
Latin America Orphan Drugs Market, by Drug Type
- Biologics
- Non-biologics
-
Latin America Orphan Drugs Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
- Brazil
- Brazil Orphan Drugs Market, by Therapy Type
- Oncology
- Hematology
- Neurology
- Endocrinology
- Cardiovascular
- Respiratory
- Immunotherapy
- Infectious Diseases
- Others
- Brazil Orphan Drugs Market, by Drug Type
- Biologics
- Non-biologics
- Brazil Orphan Drugs Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
- Brazil Orphan Drugs Market, by Therapy Type
- Argentina
- Argentina Orphan Drugs Market, by Therapy Type
- Oncology
- Hematology
- Neurology
- Endocrinology
- Cardiovascular
- Respiratory
- Immunotherapy
- Infectious Diseases
- Others
- Argentina Orphan Drugs Market, by Drug Type
- Biologics
- Non-biologics
- Argentina Orphan Drugs Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
- Argentina Orphan Drugs Market, by Therapy Type
-
Rest of Latin America
- Rest of Latin America Orphan Drugs Market, by Therapy Type
- Oncology
- Hematology
- Neurology
- Endocrinology
- Cardiovascular
- Respiratory
- Immunotherapy
- Infectious Diseases
- Others
- Rest of Latin America Orphan Drugs Market, by Drug Type
- Biologics
- Non-biologics
- Rest of Latin America Orphan Drugs Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
- Rest of Latin America Orphan Drugs Market, by Therapy Type
-
Latin America Orphan Drugs Market, by Therapy Type
- Middle East & Africa
-
Middle East & Africa Orphan Drugs Market, by Therapy Type
- Oncology
- Hematology
- Neurology
- Endocrinology
- Cardiovascular
- Respiratory
- Immunotherapy
- Infectious Diseases
- Others
-
Middle East & Africa Orphan Drugs Market, by Drug Type
- Biologics
- Non-biologics
-
Middle East & Africa Orphan Drugs Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
- GCC Countries
- GCC Countries Orphan Drugs Market, by Therapy Type
- Oncology
- Hematology
- Neurology
- Endocrinology
- Cardiovascular
- Respiratory
- Immunotherapy
- Infectious Diseases
- Others
- GCC Countries Orphan Drugs Market, by Drug Type
- Biologics
- Non-biologics
- GCC Countries Orphan Drugs Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
- GCC Countries Orphan Drugs Market, by Therapy Type
- South Africa
- South Africa Orphan Drugs Market, by Therapy Type
- Oncology
- Hematology
- Neurology
- Endocrinology
- Cardiovascular
- Respiratory
- Immunotherapy
- Infectious Diseases
- Others
- South Africa Orphan Drugs Market, by Drug Type
- Biologics
- Non-biologics
- South Africa Orphan Drugs Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
- South Africa Orphan Drugs Market, by Therapy Type
-
Rest of Middle East & Africa
- Rest of Middle East & Africa Orphan Drugs Market, by Therapy Type
- Oncology
- Hematology
- Neurology
- Endocrinology
- Cardiovascular
- Respiratory
- Immunotherapy
- Infectious Diseases
- Others
- Rest of Middle East & Africa Orphan Drugs Market, by Drug Type
- Biologics
- Non-biologics
- Rest of Middle East & Africa Orphan Drugs Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
- Rest of Middle East & Africa Orphan Drugs Market, by Therapy Type
-
Middle East & Africa Orphan Drugs Market, by Therapy Type
- North America
FAQ
Frequently Asked Question
What is the global demand for Orphan Drugs in terms of revenue?
-
The global Orphan Drugs valued at USD 177 Billion in 2023 and is expected to reach USD 505 Billion in 2032 growing at a CAGR of 12.4%.
Which are the prominent players in the market?
-
The prominent players in the market are F. Hoffmann-La Roche Ltd., Bristol-Myers Squibb Company, Johnson & Johnson, AstraZeneca, Novartis AG, Amgen Inc., Bayer AG, Novo Nordisk A/S, Daiichi Sankyo Company, GlaxoSmithKline plc, Alexion Pharmaceuticals Inc., Biogen Inc., Pfizer Inc., Sanofi S.A..
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 12.4% between 2024 and 2032.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Orphan Drugs include
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Orphan Drugs in 2023.
